Literature DB >> 16329567

Chronic hepatitis B infection in Malaysians.

S F Yap1.   

Abstract

Chronic hepatitis B virus (HBV) infection constitutes a major public health problem particularly in developing countries in East Asia, South-East Asia, the Pacific Basin and Africa. In Malaysia, a developing nation in the South East Asian region, the chronic HBV carrier rate varies between < 1% to about 10% depending on the ethnic group studied. The highest frequency is seen among the Chinese, followed by the Malays and lastly the Indians, with a male preponderance of between 2 : 1 and 3 : 1. Exposure to the virus among the adult population is estimated to be about 15%, 26% and 36% among the Indians, Malays and Chinese respectively. Serological study of adult chronic HBV carriers showed a frequency of HBe antigenemia of about 35%, with a significant decreasing trend with age. HBV DNA status generally correlated with the HBe status. An atypical profile of anti-HBe associated with serum HBV DNA is found in some carriers; in most instances, this is related to seroconversion from HBe antigenemia to anti-HBe. Chronic complications of HBV infection include the development of hepatocellular carcinoma (HCC), the occurrence of which closely parallel that of HBsAg carrier rate. In Malaysia, HCC is the third most common malignant neoplasm and among the 10 leading causes of death. About 80% of our HCC cases are HBV associated. All 3 ethnic groups are afflicted, the highest frequency being among the Chinese. Males show a disproportionate risk with an odds ratio of 3.93 (p < 0.0001).

Entities:  

Mesh:

Year:  1994        PMID: 16329567

Source DB:  PubMed          Journal:  Malays J Pathol        ISSN: 0126-8635            Impact factor:   0.656


  3 in total

1.  Interleukin-6 gene variants are associated with reduced risk of chronicity in hepatitis B virus infection in a Malaysian population.

Authors:  Behnaz Riazalhosseini; Zahurin Mohamed; Yamunah Devi Apalasamy; Noor Shafila Shafie; Rosmawati Mohamed
Journal:  Biomed Rep       Date:  2018-07-09

2.  Hepatitis Screening and Treatment Campaign in Malaysia-Validation of Low-cost Point of Care Screening Tests and Nucleic Acid Tests for Hepatitis B and C.

Authors:  Muhammad Radzi Ah; Soek S Tan; Rosmawati Mohamed; Fauziah Jaya; Senamjit K; Azlida C Aun; Ghazali A Kutty; Hin S Wong; Rafidah Abdullah; Mohd R Seman; Mamun Al Mahtab; Zaki Morad; Teck-Onn Lim
Journal:  Euroasian J Hepatogastroenterol       Date:  2019-02-01

Review 3.  Hepatitis in Malaysia: Past, Present, and Future.

Authors:  Ruksana Raihan
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.